Johnson & Johnson
JNJDividend King • 62yrsAutomated dividend-safety read-out from payout, leverage, yield, profitability and track record. See the Financials tab for the full per-statement Financial Investigation. Educational only — not investment advice.
At a glance
Johnson & Johnson (JNJ) operates in the Drug Manufacturers - General industry and is based in the United States. It pays a quarterly dividend of $5.36 a year, a yield of 2.03% at the current price of $263.81. Johnson & Johnson has raised its dividend for 62 consecutive years, which makes it a Dividend King. Over the last five years the dividend has grown by an average of 5.3% a year. It paid out 80% of its earnings as dividends. 23 analysts cover it; their average 12-month price target of $279.41 is 5.9% above the current price.
Written automatically from the figures on this page, as of Oct 24, 2026. Facts only, not a recommendation.
About Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use.
Business description sourced from Yahoo Finance / company filings. Not affiliated with SimplyWallStreet.
Key Metrics
Valuation
Profitability
Financial Health
Data provided by Yahoo Finance via yfinance. Updated daily. Not investment advice.